학술논문

S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
Document Type
Article
Source
In The Lancet Oncology August 2020 21(8):1045-1056
Subject
Primary Research
Articles
Language
ISSN
1470-2045